Home > Formulary : Paediatric > Paediatric Chapters > 2. Cardiovascular system >
BNSSG Paediatric Joint Formulary
2.6 Hyperlipidaemia
Last edited: 15-01-2024
2.6 Hyperlipidaemia
First line drugs |
Second line drugs |
Specialist drugs |
Secondary care drugs |
Secondary Care to maintain responsibility for monitoring amber specialist initiated drugs in the cardiovascular section of the Paediatric formulary. A clear management plan detailed in the clinic letter is required to support primary care prescribing. GP Practices should ensure a plan is in place before taking over prescribing responsibility
Lipid-regulating Drugs
Bile Acid Sequestrants
Colestyramine (TLS Amber specialist initiated)
Cholesterol Absorption Inhibitors
Ezetimibe (TLS Amber specialist initiated)
Fibrates
Fenofibrate (micronised or modified-release) (TLS Amber specialist initiated)
Bezafibrate (TLS Amber specialist initiated)
Statins
Atorvastatin (TLS Amber specialist initiated)
Rosuvastatin (TLS Amber specialist initiated)
Simvastatin (TLS Amber specialist initiated)
Pravastatin (TLS Amber specialist initiated)